Promoting patient-centered care in CAR-T therapy for hematologic malignancy: a qualitative meta-synthesis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Promoting patient-centered care in CAR-T therapy for hematologic malignancy: a qualitative meta-synthesis ; volume:32 ; number:9 ; day:16 ; month:8 ; year:2024 ; pages:1-12 ; date:9.2024
Supportive care in cancer ; 32, Heft 9 (16.8.2024), 1-12, 9.2024
- Urheber
-
Xie, Caiqin
Duan, Haoran
Liu, Hui
Wang, Yunhua
Sun, Zhuanyi
Lan, Meijuan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-024-08799-3
- URN
-
urn:nbn:de:101:1-2412012111290.859614667670
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xie, Caiqin
- Duan, Haoran
- Liu, Hui
- Wang, Yunhua
- Sun, Zhuanyi
- Lan, Meijuan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Current hematologic malignancy reports
CAR-T cell combination therapies in hematologic malignancies
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
A Review of the Application of mNGS in Hematologic Malignancy
Predictors of intensive care unit admission in patients with hematologic malignancy
Learning curve: machine learning takes on pediatric hematologic malignancy risk-stratification
Relapse and Resistance to CAR-T Cells and Blinatumomab in Hematologic Malignancies
Morphological diagnosis of hematologic malignancy using feature fusion-based deep convolutional neural network
Barnase-barstar Specific Interaction Regulates Car-T Cells Cytotoxic Activity toward Malignancy
Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population
Infections in hematologic malignancy patients treated by CD19 chimeric antigen receptor T‐cell therapy
Current hematologic malignancy reports
CAR-T cell combination therapies in hematologic malignancies
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
A Review of the Application of mNGS in Hematologic Malignancy
Predictors of intensive care unit admission in patients with hematologic malignancy
Learning curve: machine learning takes on pediatric hematologic malignancy risk-stratification
Relapse and Resistance to CAR-T Cells and Blinatumomab in Hematologic Malignancies
Morphological diagnosis of hematologic malignancy using feature fusion-based deep convolutional neural network
Barnase-barstar Specific Interaction Regulates Car-T Cells Cytotoxic Activity toward Malignancy
Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population
Infections in hematologic malignancy patients treated by CD19 chimeric antigen receptor T‐cell therapy
Current hematologic malignancy reports
CAR-T cell combination therapies in hematologic malignancies
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
A Review of the Application of mNGS in Hematologic Malignancy
Predictors of intensive care unit admission in patients with hematologic malignancy
Learning curve: machine learning takes on pediatric hematologic malignancy risk-stratification
Relapse and Resistance to CAR-T Cells and Blinatumomab in Hematologic Malignancies
Morphological diagnosis of hematologic malignancy using feature fusion-based deep convolutional neural network
Barnase-barstar Specific Interaction Regulates Car-T Cells Cytotoxic Activity toward Malignancy
Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population